N-of-1 Trials in Cancer Drug Development
Open Access
- 18 April 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
- Vol. 13 (6) , 1301-1309
Abstract
Summary: The current approaches for cancer drug development lag behind an accelerated need in the field for a fast and efficient method for evaluating drugs in the personalized medicine era. In that regard, N-of-1 studies emerge as a potential addition to the drug development arsenal, although there are several considerations before its broad application becomes feasible. In essence, N-of-1 trials are a departure from the traditional “drug-centric” model to a “patient-centric” model. Herein, we review the concept of N-of-1 trials and provide real-world examples of their use in the developmental therapeutics field. N-of-1 trials offer an exceptional opportunity for fast-tracking of cancer drug development in the precision oncology era.Keywords
Funding Information
- National Institutes of Health (R01CA242845)
- National Institutes of Health (R01CA273168)
- University of Texas MD Anderson Cancer Center (P30 CA016672)
This publication has 53 references indexed in Scilit:
- Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors inALK-Rearranged Lung CancerCancer Discovery, 2016
- N-of-1 trials can be aggregated to generate group mean treatment effects: a systematic review and meta-analysisJournal of Clinical Epidemiology, 2016
- Fast-tracking novel drugs in pediatric oncologyCell Cycle, 2015
- N-of-1 Trials in the Medical LiteratureMedical Care, 2011
- There are no bad anticancer agents, only bad clinical trial designs--twenty-first Richard and Hinda Rosenthal Foundation Award Lecture.1998
- EFFECT OF TETRAHYDROAMINOACRIDINE ON COGNITION, FUNCTION AND BEHAVIOR IN ALZHEIMERS-DISEASE1991
- N of 1 randomized trials for investigating new drugsControlled Clinical Trials, 1990
- A CLINICIANS GUIDE FOR CONDUCTING RANDOMIZED TRIALS IN INDIVIDUAL PATIENTS1988
- Determining Optimal Therapy — Randomized Trials in Individual PatientsNew England Journal of Medicine, 1986
- The Self-Controlled and Self-Recorded Clinical Trial for Low-Grade MorbidityJournal of Epidemiology and Community Health, 1953